BAM Logo

Automated Differential

EPTIS factsheet 580293 | Last revision 2020-12-01 | URL: https://www.eptis.bam.de/pts580293 https://www.eptis.bam.de/pts580293

PT provider
Based in Australia
Language(s) English
Remarks Material is provided to assess the white cell differential from 3-part of 5-part differential from automated instruments. |Option 1:Sysmex Corporation: XT series, XEseries, XS series, XN series, Mindray BC 5000/6000 series |Option 2: Abbott Laboratories: Cell-Dyn 3000, 3200/Ruby, 3500, 3700, 4000/Sapphire |Option 3: Beckman Coulter: Act 5 Diff, ABX Pentra 60C+ |Option 4:Bayer Diagnostics: ADVIA 120/2120 |Option 7: Beckman Coulter: MaxM, HMX, LH 500/750/755/780, GENS, Unicell Dx
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Stabilised whole blood WDB Differential (WCC, Neut/Gran, Lymph, Mono, Eos, Baso) -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by NATA on the basis of Accredited by NATA on the basis of Accredited by NATA on the basis of ISO/IEC 17043: 2010

Operation is commissioned / requested by
Fees and frequency
Participation fee Yes
Regularly operated Yes (2 samples per survey/4 surveys)
Year of first operation
Contact details of the PT provider
Provider Contact person
Suite 201/8 Herbert Street
St Leonards, 2065

Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Web: https://www.rcpaqap.com.au/ https://www.rcpaqap.com.au/
Mr Rhys Judd
Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Email: rhys.judd@rcpaqap.com.au rhys.judd@rcpaqap.com.au
If you find any mistakes please contact the responsible EPTIS coordinator in Australia, Ms Luminita Antin. Ms Luminita Antin.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5